Cord blood is the cure for genetic diseases namely thalassemia. Stem cells and tissue extracted from various sources like menstrual blood, fat cells, bone marrow and umbilical cord blood cells. Stem cells extracted from umbilical cord blood cells and tissue contains the richest potential and are highest in number. Stem cells are the master cells in the body. These master cells contains the potential to repair and regenerate the muscle, bone, skin, nerve and heart cells and tissue.
Therefore, stem cells are accredited in treating 80+ chronic ailments as well as genetic diseases. Stem cells have offered hope for the patients born with a disease and for those who are at greater risk of developing the disease. Moreover, stem cells of an individual can be useful in treating others in the family whether immediate or extended.
Fortunately, stem cells have opened up a hope for the humanity across the globe. Researchers and physicians across the world are attracted towards the research of stem cells due to their immaculate potential and future prospects in regenerative clinical trials. On the other hand, the global burden of disease can also be expected to be treated from the phenomenal potential of cord blood cells and tissue. Besides this the awareness regarding the importance of cord blood cells and tissue has become convenient due to IT revolution.
Imperatively, the awareness of cord blood cells and tissue needs to be addressed as soon as possible in order to cater the global burden of disease. Each state needs to take serious initiatives towards this public health intervention. As curing genetic illnesses has become a real threat facing humanity. The only intervention that could help all states to address the issue is the intervention of cord blood cells and tissue. Nonetheless, the intervention will take decades to put up a pace in catering the issue of treating genetic illnesses